| P2093 | author name string | Suresh C Tyagi | |
| | Brian D Hoit | |
| P2860 | cites work | Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 | Q24322566 |
| | Signal transduction from the extracellular matrix | Q24675031 |
| | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 |
| | Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells | Q28581437 |
| | Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases | Q33179376 |
| | Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. | Q35580538 |
| | A metalloproteinase inhibitor as an inhibitor of neovascularization | Q36715103 |
| | Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction | Q37527656 |
| | Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis | Q39801237 |
| | The extracellular matrix as a cell survival factor | Q40241699 |
| | Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress | Q40954699 |
| | Proteinases and myocardial extracellular matrix turnover | Q41377034 |
| | TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts | Q41535368 |
| | Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum | Q41639433 |
| | Differential responses of adult cardiac fibroblasts to in vitro biaxial strain patterns | Q41696858 |
| | Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). | Q41888678 |
| | Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients | Q42547596 |
| | Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress | Q43649151 |
| | Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength | Q43680785 |
| | Induction of oxidative stress by homocyst(e)ine impairs endothelial function | Q43704447 |
| | Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats | Q43917309 |
| | Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure | Q44061699 |
| | Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells | Q47903075 |
| | Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments | Q50335746 |
| | MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition | Q58402470 |
| P433 | issue | 4 | |
| P304 | page(s) | 241-246 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology and Therapeutics | Q1855644 |
| P1476 | title | Metalloproteinase in myocardial adaptation and maladaptation | |
| P478 | volume | 7 | |